← Wiki Index / Microbiology & Immunology / Chromobacterium violaceum
🦠 Microbiology & Immunology

Chromobacterium violaceum

Chromobacterium violaceum is a motile, facultatively anaerobic Gram-negative beta-proteobacterium of tropical and subtropical soil and aquatic ecosystems that synthesizes the purple bis-indole pigment violacein under acyl-homoserine lactone quorum-sensing control.

Chromobacterium violaceum is a motile, non-spore-forming, facultatively anaerobic Gram-negative bacteria species that inhabits tropical and subtropical soil and freshwater ecosystems worldwide. Classified within the family Chromobacteriaceae of the order Neisseriales (class Betaproteobacteria), the organism is renowned in environmental and molecular microbiology and the human microbiome research for producing violacein, a brilliant metallic dark-violet bis-indole secondary metabolite derived from the condensation of two L-tryptophan molecules. Because violacein biosynthesis is governed by a canonical LuxI/LuxR-type acyl-homoserine lactone (AHL) signaling circuit (CviI/CviR), Pigmented and colorless transposon-insertion mutants of C. violaceum (such as strain CV026) serve globally as standard biosensor reporters for bacterial quorum sensing and quorum-quenching natural products. Although C. violaceum is primarily a free-living saprophyte adapted to warm riverbanks and stagnant waters between latitudes 35° N and 35° S, percutaneous inoculation of contaminated water or soil into cutaneous wounds—especially in individuals with chronic granulomatous disease (CGD) or glucose-6-phosphate dehydrogenase (G6PD) deficiency—can trigger necrotizing cellulitis, fulminant bacteremia, and visceral microabscesses in the liver, lungs, and spleen, sharing tropical aquatic epidemiology with Aeromonas hydrophila, Plesiomonas shigelloides, and Edwardsiella tarda.

Taxonomy, Genome Architecture, and Cellular Physiology

First described by Boisbaudran in 1882 from violet-stained wet linen and named Chromobacterium violaceum by Bergonzini in 1881, the genus Chromobacterium belongs to the family Chromobacteriaceae (formerly grouped within Neisseriaceae) of the class Betaproteobacteria. Over the past two decades, polyphasic taxonomic analyses have expanded the genus to include several closely related pigmented and non-pigmented species—such as C. subtsugae, C. haemolyticum, C. aquaticum, C. piscinae, and C. vaccinii—distinguished by whole-genome average nucleotide identity (ANI), hemolytic activity, and acyl-homoserine lactone chain length specificity.

The complete genome of the type strain Chromobacterium violaceum ATCC 12472T comprises a single circular chromosome of 4,751,080 base pairs with a high guanine-plus-cytosine (G+C) content of 64.83%, encoding 4,431 predicted open reading frames. Genomic analysis reveals a versatile metabolic repertoire suited for fluctuating soil and aquatic habitats, including complete pathways for aerobic respiration, anaerobic nitrate reduction, and mixed-acid fermentation of glucose, alongside extensive operons for heavy-metal efflux, chitinase degradation, hydrogen cyanide (HCN) biogenesis, and two distinct Type III Secretion Systems (Cpi-1/1a and Cpi-2) homologous to the Salmonella pathogenicity islands SPI-1 and SPI-2.

Microscopically, C. violaceum cells are straight or slightly curved rods with rounded ends measuring 0.6 to 0.9 μm in width and 1.5 to 3.0 μm in length. The bacterium exhibits rapid swimming and swarming motility powered by two distinct flagellar systems encoded by separate gene clusters: a single constitutive polar flagellum driven by sodium motive force for swimming in liquid media, and multiple inducible lateral (peritrichous) flagella driven by proton motive force for swarming across viscous or solid surfaces.

On sheep blood, nutrient, or MacConkey agar incubated at 30 °C to 37 °C for 24 to 48 hours, C. violaceum forms smooth, convex, low-conical colonies measuring 1.5 to 3.0 mm in diameter that develop a deep violet-to-black metallic sheen and emit a characteristic almond-like odor attributable to biological cyanide production. Approximately 9% to 11% of clinical and environmental isolates are non-pigmented (achromogenic) variants that lack functional violacein expression; in routine laboratories, these unpigmented strains must be differentiated carefully from oxidase-positive aquatic rods such as Aeromonas hydrophila, Plesiomonas shigelloides, Vibrio spp., and Burkholderia pseudomallei.

Diagnostic CharacteristicChromobacterium violaceumAeromonas hydrophilaPlesiomonas shigelloidesBurkholderia pseudomallei
Taxonomic ClassBetaproteobacteriaGammaproteobacteriaGammaproteobacteriaBetaproteobacteria
Colonial PigmentDeep violet (violacein, ~90%)Buff to creamGrayish-whiteCream to wrinkled metallic
Glucose MetabolismFermentative (acid, no gas)Fermentative (acid ± gas)Fermentative (acid, no gas)Oxidative (non-fermenter)
Inositol & MannitolNegative / NegativeNegative / PositivePositive / NegativePositive / Positive
Characteristic OdorAmmonium cyanide (almond-like)Musty or earthyNoneEarthy / putrid

Violacein Biosynthesis and CviI/CviR Quorum Sensing

The signature purple pigment of C. violaceum is a hydrophobic mixture composed of roughly 85% to 90% violacein—specifically 3-[1,2-dihydro-5-(5-hydroxy-1H-indol-3-yl)-2-oxo-3H-pyrrol-3-ylidene]-1,3-dihydro-2H-indol-2-one—and 10% to 15% deoxyviolacein (which lacks the 5-hydroxyl group on the indole ring). Violacein is completely insoluble in water, localizing within the bacterial outer membrane and secreted outer-membrane vesicles, where it absorbs ultraviolet and visible radiation strongly at 575 nm, protects the cell against lipid peroxidation, and lyses bacterivorous freshwater nanoflagellate protozoa (Bodo, Rhynchomonas, and Tetrahymena species) as well as competing Gram-positive bacteria such as Staphylococcus aureus and Bacillus species.

Biosynthesis of violacein from two molecules of L-tryptophan and molecular oxygen (O2)—explaining why cultures grown under strict anaerobic conditions remain completely unpigmented—is catalyzed by five enzymes encoded on the 7.3-kilobase vioABCDE operon:

  1. VioA (Flavin-Dependent L-Tryptophan Oxidase): Oxidizes L-tryptophan to indole-3-pyruvic acid imine (IPA imine), reducing FAD and generating H2O2.
  2. VioB (Heme-Containing Iminophenylpyruvate Dimerase): Catalyzes the oxidative coupling of two IPA imine molecules into a transient short-lived dimer intermediate.
  3. VioE (Scaffold Catalyzer Protein): A non-cofactor lipoprotein that intercepts the reactive VioB dimer and directs a [1,2]-shift rearrangement of an indole ring to yield protodeoxyviolaceinic acid (rather than spontaneous off-pathway chromopyrrolic acid).
  4. VioD (NADPH-Dependent Flavin Monooxygenase): Hydroxylates the C-5 position of one indole ring to form proviolacein.
  5. VioC (NADPH-Dependent Monooxygenase): Oxygenates the C-2 position of the central pyrrolinone ring, followed by spontaneous oxidative decarboxylation to yield mature violacein.

Transcription of the vioABCDE operon, along with genes encoding extracellular chitinases, elastases, and the hcnABC hydrogen cyanide synthase complex (which oxidizes glycine into HCN and CO2), is controlled by the CviI/CviR quorum-sensing system. In the ATCC 12472T lineage, the autoinducer synthase CviI synthesizes N-hexanoyl-L-homoserine lactone (C6-HSL), whereas in the ATCC 31532 lineage, CviI synthesizes N-decanoyl-L-homoserine lactone (C10-HSL). Once extracellular AHL concentrations surpass a critical population-density threshold during late exponential growth, AHL diffuses back across the cell envelope and binds the cytoplasmic homodimeric receptor CviR, triggering a conformational change that enables its C-terminal helix-turn-helix domain to bind a 16-base-pair palindromic lux-box operator upstream of the vioA promoter.

The widely used biosensor mutant CV026—generated via mini-Tn*5* transposon insertion into the cviI autoinducer synthase gene of strain ATCC 31532—produces white colonies in monoculture because it cannot synthesize endogenous AHLs. However, when exposed to exogenous short-chain AHLs (C4-HSL to C8-HSL) produced by neighboring bacteria, CV026 restores violacein transcription and turns dark purple, whereas exposure to long-chain AHLs (C10-HSL to C14-HSL) competitively antagonizes C6-HSL binding by stabilizing a closed, cross-subunit conformation of the CviR dimer that cannot bind DNA.

Opportunistic Pathogenesis and Clinical Management

Although human infection is uncommon (with fewer than 250 documented cases globally, concentrated in Southeast Asia, northern Australia, Brazil, and the southeastern United States during warm summer months), invasive C. violaceum disease carries an overall case-fatality rate of 35% to 53%. Transmission occurs when skin abrasions, lacerations, insect bites, or trauma are exposed to warm stagnant water or muddy soil, or following near-drowning aspiration.

Clinical progression begins after an incubation period of 3 to 14 days with localized cellulitis, violaceous or bullous skin pustules, and regional lymphadenitis at the inoculation site, followed by rapid hematogenous dissemination. Systemic bacteremia is characterized by high fever, septic shock, disseminated intravascular coagulation, and multiple cavitating abscesses across the liver, lungs, spleen, lymph nodes, and brain. Because clinical presentation in endemic regions closely mimics acute septicemic melioidosis caused by Burkholderia pseudomallei, blood and pus cultures are essential for differentiation.

Patients with chronic granulomatous disease (CGD)—an X-linked or autosomal recessive phagocyte NADPH oxidase defect—and severe neutrophil G6PD deficiency are markedly predisposed to invasive C. violaceum infection. Because C. violaceum expresses elevated levels of both catalase and superoxide dismutase, it efficiently detoxifies its own endogenous metabolic hydrogen peroxide (H2O2). In CGD neutrophils that cannot generate a respiratory burst, the bacterium cannot be killed via peroxide-mediated myeloperoxidase halide halogenation, surviving and replicating within phagocytes after deploying its Cpi-1 Type III Secretion System and pore-forming hemolysins to escape into the cytosol.

Antimicrobial Susceptibility

Chromobacterium violaceum is intrinsically resistant to penicillins (ampicillin, amoxicillin-clavulanate, ticarcillin) and first-, second-, and third-generation cephalosporins (cefazolin, cefuroxime, ceftriaxone, ceftazidime) due to two inducible chromosomally encoded β-lactamases: an AmpC-type class C cephalosporinase and a CphA-like class B2 metallo-β-lactamase. It is also intrinsically resistant to colistin and polymyxin B via lipid A aminoarabinose modification.

Effective empirical and targeted antimicrobial therapy relies on fluoroquinolones (ciprofloxacin or levofloxacin, which exhibit the lowest MICs and strong intracellular penetration), carbapenems (meropenem or imipenem, often retaining activity despite variable metallo-β-lactamase expression), trimethoprim-sulfamethoxazole, aminoglycosides (gentamicin, amikacin), chloramphenicol, or tetracyclines (doxycycline, tigecycline). Due to the high frequency of visceral microabscesses and late relapse, combination parenteral therapy (such as ciprofloxacin plus meropenem or gentamicin) for 2 to 4 weeks followed by prolonged oral maintenance therapy with trimethoprim-sulfamethoxazole or ciprofloxacin for 1 to 3 months is recommended.

Frequently Asked Questions

How is Chromobacterium violaceum strain CV026 used to study bacterial quorum sensing?

Strain CV026 is a transposon mutant carrying an inactivated cviI gene, preventing it from synthesizing its own acyl-homoserine lactone (AHL) signal molecules while retaining a functional CviR receptor and intact vioABCDE pigment operon. In laboratory bioassays, CV026 grows as white colonies unless stimulated by exogenous short-chain AHLs from test bacteria (which turn the indicator lawn purple), or it can be pre-seeded with C6-HSL to screen plant extracts and synthetic compounds for quorum-sensing inhibition (which produce colorless halos around test disks).

Why are patients with Chronic Granulomatous Disease (CGD) susceptible to Chromobacterium violaceum?

Phagocytes in patients with CGD lack a functional NADPH oxidase complex and cannot generate superoxide radicals or hydrogen peroxide (H2O2) during phagocytosis. While catalase-negative bacteria supply their own metabolic H2O2 that allows CGD neutrophils to kill them, C. violaceum produces abundant catalase and superoxide dismutase that scavenge endogenous peroxides, allowing the bacterium to survive inside CGD neutrophils and disseminate to the liver and lungs.

Why are third-generation cephalosporins like ceftriaxone ineffective against Chromobacterium violaceum?

Chromobacterium violaceum carries inducible chromosomal genes encoding a class C AmpC cephalosporinase alongside a class B metallo-β-lactamase that rapidly hydrolyze penicillins, cephalexin, cefotaxime, ceftriaxone, and ceftazidime. Empirical treatment with ceftriaxone is strongly associated with fatal therapeutic failure, necessitating early use of ciprofloxacin, meropenem, or trimethoprim-sulfamethoxazole.

References

  1. Brazilian National Genome Project Consortium. (2003). The complete genome sequence of Chromobacterium violaceum reveals remarkable and exploitable bacterial adaptability. Proceedings of the National Academy of Sciences, 100(20), 11660–11665. https://doi.org/10.1073/pnas.1832124100
  2. McClean, K. H., Winson, M. K., Fish, L., Taylor, A., Chhabra, S. R., Camara, M., Daykin, M., Lamb, J. H., Swift, S., Bycroft, B. W., Stewart, G. S. A. B., & Williams, P. (1997). Quorum sensing and Chromobacterium violaceum: exploitation of violacein production and inhibition for the detection of N-acylhomoserine lactones. Microbiology, 143(12), 3703–3711. https://doi.org/10.1099/00221287-143-12-3703
  3. Balibar, C. J., & Walsh, C. T. (2006). In vitro biosynthesis of violacein from L-tryptophan by the five enzymes VioA–E from Chromobacterium violaceum. Biochemistry, 45(51), 15444–15457. https://doi.org/10.1021/bi061998z
  4. Yang, C. H., & Li, Y. H. (2011). Chromobacterium violaceum infection: a clinical review of an important but neglected infection. Journal of the Chinese Medical Association, 74(10), 435–441. https://doi.org/10.1016/j.jcma.2011.08.013
🧬 Support Open Science
Explore interactive science games on LowKey Games or browse scientific apparel & accessories in the CRV Science Shop.
💡 Spot an inaccuracy or have primary literature to expand this article?
Submit a citation or revision note using your shared CRV Science / LowKey Games profile ID.
Suggest Revision